J. Sidhu

发表

Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema

M. Hutmacher, T. Machnig, T. Craig, 2018, CPT: pharmacometrics & systems pharmacology.

Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study

J. Taubel, J. Sidhu, C. Otoul, 2013, PloS one.

Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodeficiency

J. Edelman, M. Rojavin, M. Pfister, 2014, Biologics in therapy.

Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema

P. Keith, J. Bernstein, W. Lumry, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects.

J. Ascher, E. Francis, J. Sidhu, 2006, British journal of clinical pharmacology.

Population pharmacokinetics of a new long‐acting recombinant coagulation factor IX albumin fusion protein for patients with severe hemophilia B

M. Morfini, E. Santagostino, D. Bensen-Kennedy, 2016, Journal of thrombosis and haemostasis : JTH.

Population pharmacokinetics of recombinant coagulation factor VIII‐SingleChain in patients with severe hemophilia A

M. Tortorici, A. Veldman, J. Sidhu, 2017, Journal of thrombosis and haemostasis : JTH.

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.

J. Sidhu, R. Philipson, Sunita Singh, 2006, British journal of clinical pharmacology.

A bi-directional pharmacokinetic interaction study of lamotrigine and the Combined Oral Contraceptive (COC) pill in healthy subjects

D. Blum, J. Sidhu, S. Bulsara, 2005 .

Lack of Pharmacokinetic Interaction between Oxcarbazepine and Lamotrigine

J. Ascher, J. Palmer, J. Sidhu, 2005, Neuropsychopharmacology.

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

J. Bernstein, T. Craig, M. Cicardi, 2015, Allergy.

Pharmacokinetic Modeling and Simulation of Biweekly Subcutaneous Immunoglobulin Dosing in Primary Immunodeficiency

C. Landersdorfer, C. Kirkpatrick, J. Edelman, 2013, Postgraduate medicine.

Pharmacokinetic Modeling Predicts Different IgG Exposures Using Different IVIG-Scig Dose Conversion Factors In Patients With Primary Immune Deficiency

J. Edelman, M. Rojavin, J. Sidhu, 2014 .

Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency

M. Rojavin, M. Pfister, J. Sidhu, 2014, Clinical and experimental immunology.